tert-Butyl 4-(piperazin-1-yl)piperidine-1-carboxylate dihydrochloride

Catalog No. :
ACDEUR835
CAS No. :
686298-02-2
Molecular Formula :
C14H29Cl2N3O2
Molecular Weight :
342.31

IUPAC Name:tert-butyl 4-(piperazin-1-yl)piperidine-1-carboxylate dihydrochloride

tert-Butyl 4-(piperazin-1-yl)piperidine-1-carboxylate dihydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$69.00Login to see priceInquiryInquiry
1g98%$121.00Login to see priceInquiryInquiry
5g98%$370.00Login to see priceInquiryInquiry
10g98%$592.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 4-(piperazin-1-yl)piperidine-1-carboxylate dihydrochloride
IUPAC Nametert-butyl 4-(piperazin-1-yl)piperidine-1-carboxylate dihydrochloride
MDL No.MFCD34594585
Molecular FormulaC14H29Cl2N3O2
Molecular Weight342.31
SMILESO=C(N1CCC(N2CCNCC2)CC1)OC(C)(C)C.[H]Cl.[H]Cl
InChI KeyPXPCBHRRFNJKCY-UHFFFAOYSA-N
Synonym1-Piperidinecarboxylic acid, 4-(1-piperazinyl)-, 1,1-dimethylethyl ester, hydrochloride (1:2);tert-Butyl 4-(piperazin-1-yl)piperidine-1-carboxylate dihydrochloride
CAS No.686298-02-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACDEUR835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDEUR835 route product structure diagram
    ACDEUR835686298-02-2
Inquiry

2. ACDEUR835 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDEUR835 route product structure diagram
    ACDEUR835686298-02-2
Inquiry

Comments (0)